Anterior Uveitis Treatment Market Size, Share & Trends Report

Anterior Uveitis Treatment Market Size, Share & Trends Analysis Report By Type (Infectious Uveitis), By Therapy (Biologics), By Distribution Channel (Hospital, Retail, Online Pharmacies), By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-3-68038-450-5
Number of Report Pages: 120
Format: PDF

Historical Range: 2018 - 2022
Forecast Period: 2024 - 2030
Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
  1.2. Market Definitions
  1.3. Research Methodology
1.3.1. Information Procurement
  1.3.2. Information or Data Analysis
  1.3.3. Market Formulation & Data Visualization
  1.3.4. Data Validation & Publishing
  1.4. Research Scope and Assumptions
  1.4.1. List of Data Sources
Chapter 2. Executive Summary
  2.1. Market Outlook
  2.2. Segment Outlook
  2.3. Competitive Insights
Chapter 3. Anterior Uveitis Treatment Market Variables, Trends, & Scope
  3.1. Market Introduction/Lineage Outlook
  3.2. Market Size and Growth Prospects (USD Million)
  3.3. Market Dynamics
  3.3.1. Market Drivers Analysis
  3.3.2. Market Restraints Analysis
  3.4. Anterior Uveitis Treatment Market Analysis Tools
  3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
  3.4.1.2. Bargaining power of the buyers
  3.4.1.3. Threats of substitution
  3.4.1.4. Threats from new entrants
  3.4.1.5. Competitive rivalry
  3.4.2. PESTEL Analysis
  3.4.2.1. Political landscape
  3.4.2.2. Economic and Social landscape
  3.4.2.3. Technological landscape
  3.4.2.4. Environmental landscape
  3.4.2.5. Legal landscape
Chapter 4. Anterior Uveitis Treatment Market: Type Estimates & Trend Analysis
  4.1. Segment Dashboard
  4.2. Anterior Uveitis Treatment Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  4.3. Infectious Uveitis
  4.3.1. Infectious Uveitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.4. Non-Infectious Uveitis
  4.4.1. Non-Infectious Uveitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.4.1.1. Anterior Uveitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.4.1.2. Pan-Uveitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.4.1.3. Posterior Uveitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.4.1.4. Intermediate Uveitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Anterior Uveitis Treatment Market: Therapy Estimates & Trend Analysis
  5.1. Segment Dashboard
  5.2. Anterior Uveitis Treatment Market: Therapy Movement Analysis, 2023 & 2030 (USD Million)
  5.3. Corticosteroids
  5.3.1. Corticosteroids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.4. Immunosuppressive Therapies
  5.4.1. Immunosuppressive Therapies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.5. Biologics
  5.5.1. Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.6. Others
  5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  5.7. Pipeline Therapies
  5.7.1. Pipeline Therapies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Anterior Uveitis Treatment Market: Distribution Channel Estimates & Trend Analysis
  6.1. Segment Dashboard
  6.2. Anterior Uveitis Treatment Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
  6.3. Hospital Pharmacies
  6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.4. Retail Pharmacies
  6.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.5. Online Pharmacies
  6.5.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Anterior Uveitis Treatment Market: Regional Estimates & Trend Analysis
  7.1. Anterior Uveitis Treatment Market Share, By Region, 2023 & 2030 (USD Million)
  7.2. North America
  7.2.1. North America Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.2. U.S.
  7.2.2.1. U.S. Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.3. Canada
  7.2.3.1. Canada Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.2.4. Mexico
  7.2.4.1. Mexico Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3. Europe
  7.3.1. Europe Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.2. UK
  7.3.2.1. U K Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.3. Germany
  7.3.3.1. Germany Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.4. France
  7.3.4.1. France Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.5. Italy
  7.3.5.1. Italy Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.6. Spain
  7.3.6.1. Spain Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.7. Denmark
  7.3.7.1. Denmark Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.8. Sweden
  7.3.8.1. Sweden Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.3.9. Norway
  7.3.9.1. Norway Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4. Asia Pacific
  7.4.1. Asia Pacific Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.2. Japan
  7.4.2.1. Japan Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.3. China
  7.4.3.1. China Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.4. India
  7.4.4.1. India Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.5. Australia
  7.4.5.1. Australia Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.6. South Korea
  7.4.6.1. South Korea Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.4.7. Thailand
  7.4.7.1. Thailand Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.5. Latin America
  7.5.1. Latin America Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.5.2. Brazil
  7.5.2.1. Brazil Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.5.3. Argentina
  7.5.3.1. Argentina Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6. Middle East and Africa
  7.6.1. Middle East and Africa Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.2. South Africa
  7.6.2.1. South Africa Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.3. Saudi Arabia
  7.6.3.1. Saudi Arabia Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.4. UAE
  7.6.4.1. UAE Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  7.6.5. Kuwait
  7.6.5.1. Kuwait Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
  8.1. Recent Developments & Impact Analysis by Key Market Participants
  8.2. Company Categorization
  8.3. Company Heat Map Analysis
  8.4. Company Profiles
  8.4.1. Novartis AG
  8.4.1.1. Participant’s Overview
  8.4.1.2. Financial Performance
  8.4.1.3. Product Benchmarking
  8.4.1.4. Recent Developments/ Strategic Initiatives
  8.4.2. Santen Pharmaceutical Co., Ltd
  8.4.2.1. Participant’s Overview
  8.4.2.2. Financial Performance
  8.4.2.3. Product Benchmarking
  8.4.2.4. Recent Developments/ Strategic Initiatives
  8.4.3. AbbVie Inc.
  8.4.3.1. Participant’s Overview
  8.4.3.2. Financial Performance
  8.4.3.3. Product Benchmarking
  8.4.3.4. Recent Developments/ Strategic Initiatives
  8.4.4. Kiora Pharmaceuticals, Inc.
  8.4.4.1. Participant’s Overview
  8.4.4.2. Financial Performance
  8.4.4.3. Product Benchmarking
  8.4.4.4. Recent Developments/ Strategic Initiatives
  8.4.5. Clearside Biomedical
  8.4.5.1. Participant’s Overview
  8.4.5.2. Financial Performance
  8.4.5.3. Product Benchmarking
  8.4.5.4. Recent Developments/ Strategic Initiatives
  8.4.6. Aldeyra Therapeutics, Inc.
  8.4.6.1. Participant’s Overview
  8.4.6.2. Financial Performance
  8.4.6.3. Product Benchmarking
  8.4.6.4. Recent Developments/ Strategic Initiatives
  8.4.7. UCB S.A.
  8.4.7.1. Participant’s Overview
  8.4.7.2. Financial Performance
  8.4.7.3. Product Benchmarking
  8.4.7.4. Recent Developments/ Strategic Initiatives
  8.4.8. Agilent Technologies, Inc. (Lux Biosciences, Inc.)
  8.4.8.1. Participant’s Overview
  8.4.8.2. Financial Performance
  8.4.8.3. Product Benchmarking
  8.4.8.4. Recent Developments/ Strategic Initiatives
  8.4.9. Tarsier Pharma Ltd.
  8.4.9.1. Participant’s Overview
  8.4.9.2. Financial Performance
  8.4.9.3. Product Benchmarking
  8.4.9.4. Recent Developments/ Strategic Initiatives

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.